A recent study by the CDC revealed over 1,500 children under 2 faced serious health issues, with three fatalities, due to common cold medicines in 2004-2005.
FDA official Dr. Charles J. Ganley is reassessing the risks and benefits, especially for children under 2.
Pediatricians petitioned to restrict marketing of such medicines to kids under 6, citing common overdoses.
FDA is reviewing the safety and efficacy of these drugs for children.
Johnson & Johnson voluntarily recalled certain infant cough and cold products due to misuse.
The FDA is discussing the use of cough and cold drugs for children in an upcoming meeting.
